MY148277A - Treatment of cartilage disorders with fgf-18 - Google Patents

Treatment of cartilage disorders with fgf-18

Info

Publication number
MY148277A
MY148277A MYPI20090702A MYPI20090702A MY148277A MY 148277 A MY148277 A MY 148277A MY PI20090702 A MYPI20090702 A MY PI20090702A MY PI20090702 A MYPI20090702 A MY PI20090702A MY 148277 A MY148277 A MY 148277A
Authority
MY
Malaysia
Prior art keywords
treatment
fgf
osteoarthritis
cartilage disorders
cartilage disorder
Prior art date
Application number
MYPI20090702A
Other languages
English (en)
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of MY148277A publication Critical patent/MY148277A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
MYPI20090702A 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18 MY148277A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28

Publications (1)

Publication Number Publication Date
MY148277A true MY148277A (en) 2013-03-29

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20090702A MY148277A (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Country Status (11)

Country Link
CN (1) CN101505787B (pt)
BR (1) BRPI0715728A8 (pt)
DK (1) DK2054050T3 (pt)
ES (1) ES2392883T3 (pt)
MY (1) MY148277A (pt)
NZ (1) NZ574216A (pt)
PT (1) PT2054050E (pt)
RS (1) RS52710B (pt)
SI (1) SI2054050T1 (pt)
UA (1) UA99818C2 (pt)
ZA (1) ZA200900426B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2881024C (en) * 2012-08-06 2021-06-15 Christoph Hubertus LADEL Genetic markers for predicting responsiveness to fgf-18 compound
BR112016018704B1 (pt) * 2014-02-20 2021-01-05 Merck Patent Gmbh processo para produção de um material de cartilagem transplantável para engenharia de tecido
HRP20181573T1 (hr) * 2014-02-20 2018-11-30 Merck Patent Gmbh Implantat koji sadrži fgf-18
JP6431083B2 (ja) * 2014-02-20 2018-11-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Ｆｇｆ−１８化合物の投与計画
EP3250223A1 (en) * 2015-01-08 2017-12-06 University of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
CN107849151B (zh) * 2015-07-15 2022-05-24 德益阳光生物技术（北京）有限责任公司 融合多肽及使用方法
MX2018001816A (es) * 2015-08-13 2018-05-16 Merck Patent Gmbh Composicion combinada que comprende el compuesto fgf-18.
US12624015B2 (en) 2019-06-24 2026-05-12 University Of Iowa Research Foundation JNK inhibitors as anticancer agents
IL293141A (en) * 2019-11-21 2022-07-01 Remedium Bio Inc Growth factor restoration
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (zh) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 用于治疗骨关节炎的mRNA及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136970A1 (en) * 2002-10-07 2004-07-15 Ellsworth Jeff L. Methods for administering FGF18
ES2706848T3 (es) * 2004-07-06 2019-04-01 Zymogenetics Inc Composición farmacéutica que comprende FGF18 y antagonista de IL-1 y método de uso
SI1828239T1 (sl) * 2004-12-10 2011-11-30 Zymogenetics Inc Proizvodnja fgf18 v prokariotskih gostiteljih

Also Published As

Publication number Publication date
BRPI0715728A8 (pt) 2018-04-03
PT2054050E (pt) 2012-09-17
DK2054050T3 (da) 2012-09-03
CN101505787A (zh) 2009-08-12
UA99818C2 (ru) 2012-10-10
NZ574216A (en) 2011-11-25
ZA200900426B (en) 2010-04-28
SI2054050T1 (sl) 2012-12-31
BRPI0715728A2 (pt) 2013-09-17
RS52710B (sr) 2013-08-30
CN101505787B (zh) 2013-09-04
ES2392883T3 (es) 2012-12-14

Similar Documents

Publication Publication Date Title
WO2008023063A3 (en) Treatment of cartilage disorders with fgf-18
UA99818C2 (ru) Лечение заболеваний хряща
WO2007134326A3 (en) Methods for treating autoimmune diseases using a taci-ig fusion molecule
TW200716672A (en) Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
IL201479A (en) Use of tapentadol for the preparation of pain medication
PH12011502704A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
MY162067A (en) Combination therapy for treatment of patients with neurological disorders and cerebral infarction
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
PH12012501740A1 (en) Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
NZ597419A (en) Formulations for the treatment of deep tissue pain
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
MY150702A (en) Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them
EA201001749A1 (ru) Способ лечения недифференцированного артрита
WO2008052139A3 (en) Ultra low dose doxepin and methods of using the same to treat sleep disorders
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
UA85471C2 (ru) Применение оксикодона для лечения висцеральной боли
NZ591496A (en) A medicinal comprising ibuprofen and paracetamol and treatment for arthritis
PT1670489E (pt) Utilização de xénon com hipotermia para o tratamento de asfixia neonatal
EA201070193A1 (ru) Лечение детских опухолей
IL198202A0 (en) Peptide-cytotoxic conjugates
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
EP2124554A4 (en) COMPOSITIONS AND METHODS FOR CANCER TREATMENT